1-11 of 11 results for subject:Abbott
Librarians' tools
- Search time
- 0.302 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Abbott
- We searched for
- subject_t:Abbott OR subject_t:"Abbott Laboratories" OR subject_ses:91
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meeting between the Parliamentary Under Secretary of State for Innovation, Lord Feldman and Abbott regarding the Abbott covid-19 test on 7 April 2020; whether officials or special advisers attended the meeting...
To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meeting between the Parliamentary Under Secretary of State for Innovation, Lord Feldman and Abbott regarding the Abbott covid-19 test on 7 April 2020; whether officials or special advisers attended the meeting...
The Department does not hold a formal minute of the meeting. Lord Bethell attended the meeting with a Private Secretary, officials from the Department and the Medicines and Healthcare products Regulatory Authority, Lord Feldman of Elstree and representatives from Abbott. Special advisors did not attend the meeting. Lord Feldman of Elstree attended in an advisory capacity.
To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meeting between the Parliamentary Under Secretary of State for Innovation, Lord Feldman and Abbott on the Abbott covid-19 test on 7 April 2020; whether (a) officials and (b) special advisers attended...
To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meeting between the Parliamentary Under Secretary of State for Innovation, Lord Feldman and Abbott on the Abbott covid-19 test on 7 April 2020; whether (a) officials and (b) special advisers attended...
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on people with diabetes of the slow-down in production and shipping of Freestyle Libre glucose monitoring sensors from Abbott; and if he will make statement.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on people with diabetes of the slow-down in production and shipping of Freestyle Libre glucose monitoring sensors from Abbott; and if he will make statement.
The Department is aware of current supply issues with the Freestyle Libre glucose monitoring sensors and it is maintaining regular contact with the supplier Abbott to re-establish the reliable supply of this product.
This is a temporary disruption caused by increases in demand and we have already seen steady progress to improve the situation over the recent weeks.
The information provided refers to the National Health Service in England only.
To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.
To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.
On 14 November 2018, it was announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, in line with National Health Service clinical guidelines.
The Department has not made any representations to Abbott since.
Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This should include consideration of access to diabetes technologies such as FreeStyle Libre.
To give all funds or grants made available to NHS laboratories, hospitals or consultants for purpose of conducting research on HIV infection or AIDS by following organisations: the Wellcome Foundation, Burroughs Wellcome, Abbot Laboratories, du Pont and Glaxo, identifying organisation, amount, principal recipient & purpose of grant.
To give all funds or grants made available to NHS laboratories, hospitals or consultants for purpose of conducting research on HIV infection or AIDS by following organisations: the Wellcome Foundation, Burroughs Wellcome, Abbot Laboratories, du Pont and Glaxo, identifying organisation, amount, principal recipient & purpose of grant.
Steps taken to enable those undertaking research into treatment & care of people with HIV or AIDS to learn from experiences in United States of America.
Steps taken to enable those undertaking research into treatment & care of people with HIV or AIDS to learn from experiences in United States of America.